Clinical Trial Update: Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating oral and intravenous tranexamic acid to reduce blood loss in lumbar spine surgery; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Blood Loss
• Blood Loss During Surgery
• Lumbar Spine Disorders

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Henry Ford Health System | Conditions: Blood Loss, Surgical, Blood Loss Anemia | Phase 4 | Status: COMPLETED